Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
41.35
-2.00 (-4.61%)
Apr 30, 2026, 3:00 PM CST

SHA:688363 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
994.98719.271,1691,6061,807
Trading Asset Securities
33.2930.02140.04530.72846.89
Cash & Short-Term Investments
1,028749.291,3092,1372,654
Cash Growth
37.23%-42.75%-38.75%-19.47%25.58%
Accounts Receivable
566.78547.38450.19457.87402.22
Other Receivables
42.2645.2739.4251.9128.9
Receivables
609.05592.65489.61509.78431.12
Inventory
980.621,2481,1351,162709.13
Other Current Assets
167.05150.96189.99214.93190.37
Total Current Assets
2,7852,7413,1234,0233,984
Property, Plant & Equipment
4,0554,2033,6572,9132,305
Long-Term Investments
570.13585.02502.99592.63400.32
Goodwill
177.62174.09251.28247.2267.15
Other Intangible Assets
517.62490.63496.97475.06467.26
Long-Term Deferred Tax Assets
335.56355.56336.98302.59246.11
Long-Term Deferred Charges
155.12100.3498.14116.4331.85
Other Long-Term Assets
96.97.513.6311.51.44
Total Assets
8,6938,6578,4708,6827,504
Accounts Payable
668.09195.41186.78247.75243.55
Accrued Expenses
140.81587.09479.49672.75704.09
Short-Term Debt
92.8949.92-139.2-
Current Portion of Long-Term Debt
114.3228.89106.0836.5436.46
Current Portion of Leases
-62.7947.0553.6749.61
Current Income Taxes Payable
76.7913.8555.6876.43135.52
Current Unearned Revenue
57.7763.4855.5867.7450.83
Other Current Liabilities
39.33339.6290.13349.97180.46
Total Current Liabilities
1,1901,3411,2211,6441,401
Long-Term Debt
94.6665.122.32107.97144.18
Long-Term Leases
39.51152.9752.6652.4269.77
Long-Term Unearned Revenue
248.94253.24205.73188.68182.71
Long-Term Deferred Tax Liabilities
4.244.575.095.664.12
Total Liabilities
1,5771,8171,4871,9991,801
Common Stock
481.68481.68481.68481.09480
Additional Paid-In Capital
3,8503,8533,8413,7533,569
Retained Earnings
2,9402,7002,7082,4091,674
Treasury Stock
-219.95-219.95-105.88--
Comprehensive Income & Other
34.65-4.3219.57-9.1-23.91
Total Common Equity
7,0866,8106,9446,6345,699
Minority Interest
29.4929.6339.3349.213.45
Shareholders' Equity
7,1156,8406,9836,6835,702
Total Liabilities & Equity
8,6938,6578,4708,6827,504
Total Debt
341.38359.69208.1389.79300.01
Net Cash (Debt)
686.9389.61,1011,7472,354
Net Cash Growth
76.31%-64.60%-37.00%-25.77%12.67%
Net Cash Per Share
1.430.802.283.624.87
Filing Date Shares Outstanding
459.1478.36480.26481.09480
Total Common Shares Outstanding
459.1478.36480.26481.09480
Working Capital
1,5951,4001,9022,3792,584
Book Value Per Share
15.4314.2414.4613.7911.87
Tangible Book Value
6,3906,1456,1965,9115,165
Tangible Book Value Per Share
13.9212.8512.9012.2910.76
Buildings
-2,4961,7561,3851,269
Machinery
-1,7941,4101,148812.35
Construction In Progress
-640.981,109830.45516.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.